THERAVANCE BIOPHARMA INC (TBPH) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:TBPH • KYG8807B1068

20.1 USD
+0.11 (+0.55%)
Last: Feb 4, 2026, 02:30 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
TBPH revenue by date.TBPH revenue by date.
51.3M
-7.23%
57.424M
11.94%
64.381M
12.12%
109.95M
70.78%
102.77M
-6.53%
121.27M
18.00%
182.37M
50.38%
250.25M
37.22%
312.64M
24.93%
479.09M
53.24%
430.54M
-10.13%
641.27M
48.95%
EBITDA
YoY % growth
TBPH ebitda by date.TBPH ebitda by date.
-75.38M
67.48%
-51.291M
31.96%
-40.726M
20.60%
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
TBPH ebit by date.TBPH ebit by date.
-79.1M
66.72%
-53.292M
32.63%
-42.436M
20.37%
-3.835M
90.96%
-21.935M
-471.93%
-21.867M
0.31%
33.866M
254.87%
78.618M
132.14%
152.5M
93.98%
346.6M
127.28%
385.76M
11.30%
421.06M
9.15%
Operating Margin
TBPH operating margin by date.TBPH operating margin by date.
-154.19%-92.80%-65.91%-3.49%-21.34%-18.03%18.57%31.42%48.78%72.35%89.60%65.66%
EPS
YoY % growth
TBPH eps by date.TBPH eps by date.
-0.67
77.29%
-0.97
-44.78%
-1.09
-12.37%
1.93
277.35%
0.96
-50.14%
-0.05
-105.40%
0.82
1,681.76%
1.73
110.74%
2.54
46.28%
4.59
80.96%
1.69
-63.11%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
1.15
469.70%
-0.06
77.71%
-0.13
75.30%
-0.09
-229.32%
1.47
28.56%
Revenue
Q2Q % growth
51.809M
176.26%
24.317M
58.03%
21.665M
-17.29%
25.296M
26.54%
48.511M
-6.37%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
27.174M
395.37%
-9.869M
31.63%
-8.185M
-200.39%
-7.14M
-10.61%
24.837M
-8.60%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.07
126.92%
-0.130.20153.48%
Q2 2025
Q2Q % growth
-0.54
-92.86%
0.69-1.23-178.66%
Q1 2025
Q2Q % growth
-0.27
-12.50%
-0.23-0.04-16.10%
Q4 2024
Q2Q % growth
-0.31
-82.35%
-0.21-0.10-44.72%
Q3 2024
Q2Q % growth
-0.26
-52.94%
-0.24-0.02-10.35%
Q2 2024
Q2Q % growth
-0.28 -0.21-0.07-32.93%
Q1 2024
Q2Q % growth
-0.24
31.43%
-0.260.027.36%
Q4 2023
Q2Q % growth
-0.17
-13.33%
-0.15-0.02-12.11%
Q3 2023
Q2Q % growth
-0.17
19.05%
-0.210.0420.51%
Q2 2023
Q2Q % growth
-0.28
-211.11%
-0.21-0.07-30.72%
Q1 2023
Q2Q % growth
-0.35
-59.09%
-0.25-0.10-39.30%
Q4 2022
Q2Q % growth
-0.15
65.12%
-0.180.0314.75%
Q3 2022
Q2Q % growth
-0.21
56.25%
-0.19-0.02-12.81%
Q2 2022
Q2Q % growth
-0.09
88.75%
0.11-0.20-180.95%
Q1 2022
Q2Q % growth
-0.22
82.26%
-0.11-0.11-103.48%
Q4 2021
Q2Q % growth
-0.43
53.26%
-0.34-0.09-27.17%
Q3 2021
Q2Q % growth
-0.48
58.62%
-0.570.0915.80%
Q2 2021
Q2Q % growth
-0.80
20.00%
-1.020.2221.48%
Q1 2021
Q2Q % growth
-1.24
11.43%
-1.07-0.17-15.99%
Q4 2020
Q2Q % growth
-0.92 -1.040.1211.21%
Q3 2020
Q2Q % growth
-1.16 -1.03-0.13-12.28%
Q2 2020
Q2Q % growth
-1.00 -1.000.00-0.42%
Q1 2020
Q2Q % growth
-1.40 -1.10-0.30-27.68%
TBPH Yearly EPS VS EstimatesTBPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
19.99M
18.51%
20.359M-369K-1.81%
Q2 2025
Q2Q % growth
26.195M
83.75%
26.555M-360K-1.36%
Q1 2025
Q2Q % growth
15.388M
6.10%
15.81M-422K-2.67%
Q4 2024
Q2Q % growth
18.754M
6.77%
17.432M1.322M7.58%
Q3 2024
Q2Q % growth
16.868M
7.49%
15.65M1.218M7.78%
Q2 2024
Q2Q % growth
14.256M
3.69%
15.762M-1.506M-9.55%
Q1 2024
Q2Q % growth
14.503M
39.22%
14.242M261K1.83%
Q4 2023
Q2Q % growth
17.565M
20.31%
18.038M-473K-2.62%
Q3 2023
Q2Q % growth
15.693M
25.54%
15.302M391K2.56%
Q2 2023
Q2Q % growth
13.749M
23.86%
15.729M-1.98M-12.59%
Q1 2023
Q2Q % growth
10.417M
-21.08%
13.988M-3.571M-25.53%
Q4 2022
Q2Q % growth
14.6M
-2.01%
16.041M-1.441M-8.98%
Q3 2022
Q2Q % growth
12.5M
-5.30%
12.046M454K3.77%
Q2 2022
Q2Q % growth
11.1M
-13.95%
12.661M-1.561M-12.33%
Q1 2022
Q2Q % growth
13.2M
-7.69%
14.774M-1.574M-10.65%
Q4 2021
Q2Q % growth
14.9M
-20.32%
13.751M1.149M8.36%
Q3 2021
Q2Q % growth
13.2M
-27.87%
14.689M-1.489M-10.14%
Q2 2021
Q2Q % growth
12.9M
-14.00%
15.715M-2.815M-17.91%
Q1 2021
Q2Q % growth
14.3M
-28.14%
17.615M-3.315M-18.82%
Q4 2020
Q2Q % growth
18.7M 21.263M-2.563M-12.05%
Q3 2020
Q2Q % growth
18.3M 18.945M-645K-3.40%
Q2 2020
Q2Q % growth
15M 20.033M-5.033M-25.12%
Q1 2020
Q2Q % growth
19.9M 18.49M1.41M7.63%
TBPH Yearly Revenue VS EstimatesTBPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 361.76% 0% 105.25%
Revenue0% -2.2% 0% -5.03%